INFANRIX

GlaxoSmithKline Biologicals SA🇺🇸 United States

FDA Page

Effective Date: May 14, 2026
Approval ID: de16dd6a-859b-4180-c6af-f930be14f26a
Products: 1 registered
Version: 29

Regulatory Information

Labeling Type

VACCINE LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use INFANRIX safely and effectively. See full prescribing information for INFANRIX. INFANRIX (Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed) injectable suspension, for intramuscular useInitial U.S. Approval: 1997

Quick Stats

Total Products1

Labelers1

Label Sections34

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.